However, statistically significant differences were noted in PD-CD133/BSH groups in combination with BSH plus BNCT in CD133- glioma implanted mice (P < 0.01) and BSH plus BNCT in CD133+ glioma implanted mice (P < 0.01) compared with untreated control. The gene discussed is PROM1; the disease is glioma.